Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Carcinoma, Renal Cell 25Kidney Neoplasms 6Neoplasms 5Neoplasm Metastasis 4Clear-cell metastatic renal cell carcinoma 4Uterine Cervical Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Melanoma 2Endometrial Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Pheochromocytoma 1Paraganglioma 1Neuroendocrine Tumors 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphatic Metastasis 1Lung Neoplasms 1Kidney Diseases 1Gastrointestinal Stromal Tumors 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1

Interventions

Specimen Handling 9Magnetic Resonance Spectroscopy 6Biopsy 6pembrolizumab 3X-Rays 3Nivolumab 3olaparib 2durvalumab 2ceralasertib 2Paclitaxel 2Immunoglobulin G 2Carboplatin 2trastuzumab deruxtecan 1sargramostim 1ribociclib 1pelcitoclax 1cobimetinib 1cediranib 1capivasertib 1cabozantinib 1atezolizumab 1Tissue Banks 1Taxes 1TIC10 compound 1Radiation 1Phantoms, Imaging 1Minimally Invasive Surgical Procedures 1Ipilimumab 1Indocyanine Green 1Fulvestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinosarcoma × Axitinib × 1 year × Clear all
NCT05949632 2026-06-04

A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors

Incyte Corporation

Phase 1/2 Terminated
5 enrolled 13 charts
GynecologicSarcoma

Adenocarcinoma, Mucinous, Carcinosarcoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Cystadenocarcinoma, Serous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡